Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Is 5-Amino-1MQ approved in the UK
Originally created as a lipolytic compound for treating obesity, AOD-9604 has demonstrated potential in animal studies for treating heart disease, osteoarthritis, and metabolic syndrome by promoting cartilage repair and fat breakdown while inhibiting fat creation
Journal of Endocrinology , 2001 Demonstrated AOD9604's lipolytic properties and its selective activation of fat metabolism pathways without affecting IGF-1 levels
Inject slowly over say 30 seconds then withdraw the needle
US$ 28.20
US$ 26.87
US$ 29.00
US$ 29.13
